Based on the literature synthesis and system mapping presented in Section 2.4, a set of design requirements (DRs) was derived ...
Introduction Visual Hallucinations (VHs) (seeing things that others do not, or visions) are a common feature of psychosis, causing significant distress and disability. Services rarely ask about these ...
On December 30, astronomer Jonathan McDowell posted on X.com: “The abandoned Chandrayaan-3 propulsion module, left in a 125000 x 305000 km orbit in 2024, had a bit of a tussle with the Moon in ...
Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? There's been some back and forth in the medical community about the value of ...
Share on Pinterest According to research, most people may not be getting enough omega-3 fatty acids in their diet. Image Credit: Tanja Ivanova/Getty Images A new research review reports that most ...
The RELIEVE trial assesses remibrutinib's efficacy and safety in generalized myasthenia gravis, involving 180 participants in a 6-month double-blind study. Remibrutinib has shown a positive safety ...
1 Department of Design and Engineering, Faculty of Science and Technology, Bournemouth University, Bournemouth, UK. 2 Accounting, Finance and Economics Department, Business School, Bournemouth ...
Panelists discuss how the GALAXI-2 and GALAXI-3 trials represented a landmark study design for Crohn’s disease research through their rigorous triple-dummy active comparator methodology, treat-through ...
A study by Fraunhofer ISE, and commissioned by trade body SolarPower Europe (SPE), has concluded that reaching the EU’s solar module manufacturing target of 30GW per year is both technically and ...
DEL MAR, Calif., Sept. 23, 2025 /PRNewswire/ -- CeleCor Therapeutics' multinational Phase 3 clinical trial of its investigational heart-attack drug Disaggpro™ (zalunfiban) has shown positive primary ...
The phase 3 DRAGON study assessed tinlarebant's efficacy, safety, and tolerability in treating Stargardt disease type 1. Tinlarebant reduces vitamin A-based toxins by regulating serum retinol binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback